{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-053056","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.122763+00:00","generated_at":"2026-05-15T00:35:35.798027+00:00","sec_items":["2.02","5.02","8.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Select Medical Q1 EPS $0.35 vs $0.44; revenue +5% to $1.42B; merger on track","bullets":["Revenue $1,421.5M +5.0% YoY; net income $63.8M vs $74.7M; diluted EPS $0.35 vs $0.44.","Adj EBITDA $141.6M down from $151.4M; critical illness hospital margin fell to 11.5% from 13.6%.","Rehab hospital revenue +14.5% to $351.9M, Adj EBITDA +15.1% to $81.1M, margin stable at 23.0%.","Merger with WCAS XIV on track; HSR waiting period expired Apr 27; expected close mid-2026 at $16.50/share.","FY 2026 outlook reaffirmed: rev $5.6-5.8B, Adj EBITDA $520-540M, diluted EPS $1.22-1.32."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-053056","json":"https://secwatch.observer/filing/0001104659-26-053056.json","markdown":"https://secwatch.observer/filing/0001104659-26-053056.md","text":"https://secwatch.observer/filing/0001104659-26-053056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465926053056/0001104659-26-053056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465926053056/tm2613082d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:35:35.798027+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c04f014acffd0490c4d62308ffa6f88cbac6ef1","claim":"SELECT MEDICAL HOLDINGS CORP reported first quarter ended March 31, 2026 results: revenue $1,421.5 million, net income $63.8 million, EPS $0.35.","evidence_excerpt":"For the first quarter ended March 31, 2026, revenue increased 5.0% to $1,421.5 million, compared to $1,353.2 million for the same quarter, prior year. Income from operations was $98.4 million for the first quarter ended March 31, 2026, compared to $112.7 million for the same quarter, prior year. Net income was $63.8 million for the first quarter ended March 31, 2026, compared to $74.7 million for the same quarter, prior year. Adjusted EBITDA was $141.6 million for the first quarter ended March 31, 2026, compared to $151.4 million for the same quarter, prior year. Earnings per common share was $0.35 for the first quarter ended March 31, 2026, compared to $0.44 for the same quarter, prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1320414/000110465926053056/0001104659-26-053056-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Revenue","value":"$1,421.5 million"},{"label":"Net income","value":"$63.8 million"},{"label":"EPS","value":"$0.35"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}